Trademark: 97367616
Word
CELMOD
Status
Pending
Status Code
730
Status Date
Wednesday, January 10, 2024
Serial Number
97367616
Mark Type
4000
Filing Date
Monday, April 18, 2022
Published for Opposition
Tuesday, May 16, 2023

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use

Trademark Events
Jan 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2024
Sou Extension 1 Granted
Jan 10, 2024
Sou Extension 1 Filed
Jan 10, 2024
Sou Teas Extension Received
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
May 16, 2023
Published For Opposition
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
Apr 10, 2023
Approved For Pub - Principal Register
Apr 7, 2023
Teas/Email Correspondence Entered
Apr 7, 2023
Correspondence Received In Law Office
Apr 7, 2023
Teas Response To Office Action Received
Oct 7, 2022
Notification Of Non-Final Action E-Mailed
Oct 7, 2022
Non-Final Action E-Mailed
Oct 7, 2022
Non-Final Action Written
Sep 29, 2022
Assigned To Examiner
Apr 22, 2022
New Application Office Supplied Data Entered
Apr 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24